Members | Market | Warrants | Research | A.I. | Education | AASTOCKS | Products | US Stocks
Back to Home  
Member Service| Live Picks| Top Features| Back Test| Market| Tech Analysis| University| About Tradetrek
Block Trades | Money Flow | VWAP | Fundamentals | Historical chart walker | Back Test | Stock Code Lookup
Stock ID: Quote Chart News Fundamentals Comment 5-day Forecast 6-month Target
 
Dec 27, 2025   08:15:45 p.m.
Print  Forward
2009-4-27   10:01:00 a.m. HKT, XFNA
DJ MARKET TALK: HK Pharmaceutical Stocks Bid Up; Swine Flu Fears
 
0952 [Dow Jones] Some HK-listed pharmaceutical stocks punted much higher at pre-open: Guangzhou Pharmaceutical (0874.HK) +8.1% at HK$3.07, China Pharmaceutical (1093.HK) +9.2% at HK$4.15, Wuyi Pharmaceutical (1889.HK) +9.9% at 78 HK cents. Investors wishing to chase shares higher perhaps need to take note such sector strength on concerns of swine flu outbreak likely due to theme punting rather than actual benefits, as no HK-listed pharmaceutical firms make Tamiflu.(RLI) Contact us in Hong Kong. 852 2802 7002; MarketTalk@dowjones.com Click here to go to Dow Jones NewsPlus, a web front page of today's most important business and market news, analysis and commentary: http://www.djnewsplus.com/access/al?rnd=pRSX9uptcu5%2ButSoB0B%2FnA%3D%3D. You can use this link on the day this article is published and the following day. (Delayed by 1 hour) -0- Copyright (c) 2009 Dow Jones & Company, Inc.
 

News Provided by XFNA
 

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved
 
 

Disclaimers | Privacy Policy | Career Opportunities | Contact Us | Help
www.aastocks.com
Support Hotline:(852)2186 8685/ (852) 2121 8803
Email: support@aastocks.com
Copyright 2000 AASTOCKS.com Ltd. All rights reserved.
AASTOCKS.com LIMITED is a SFC registered Investment Advisor.
Note: AASTOCKS.com Ltd endeavors to ensure the accuracy and reliability of the information provided but does not guarantee its accuracy or reliability and accepts no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.